FDA Inspection 1203004 — Compass Group USA, Inc.
The FDA completed an inspection of Compass Group USA, Inc. on April 12, 2023 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 12, 2023
- Fiscal Year
- 2023
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Omaha, NE (United States)